Abstract
Parkinson’s disease (PD) is a dopaminergic-related pathology in which basal ganglia functioning are altered. It has been postulated that a direct receptor-receptor – i.e. dopamine D2 receptor (D2R) and adenosine A2A receptor (A2AR) – interaction may be finely regulating this brain area. Accordingly, elucidating whether the pathology prompts changes on these structures could grant valuable information for the design of new PD therapies. Here, we first resolved a long-standing question concerning D2R-A2AR assembly in native tissue. Thus, by means of different complementary experimental approaches (i.e. immunoelectron microscopy, proximity ligation assay and TR-FRET), we unambiguously identified native D2R/A2AR oligomers in rat striatum. Subsequently, we determined that under pathological conditions (i.e. in a rat PD model) D2R-A2AR interaction was impaired. Collectively, these results provide definitive evidence for a native D2R/A2AR oligomer alteration in experimental parkinsonism, thus conferring the rationale for appropriate oligomer-based PD treatments.
- Received September 4, 2014.
- Accepted November 10, 2014.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed.
Article navigation
Related articles
Cited by...
More in this TOC section
Similar articles
Other journals from The Company of Biologists
Featured article - Generation of a multipurpose Prdm16 mouse allele by targeted gene trapping
This Research article from Bryan C. Bjork and co-workers describes the first targeting of an invertible gene trap to generate a conditional Prdm16 mouse allele and its use to assess phenotypic consequences of Prdm16 loss during craniofacial and brain development.
Review - Cell models of arrhythmogenic cardiomyopathy: advances and opportunities
Elena Sommariva and colleagues reappraise past discoveries in in vitro models of arrhythmogenic cardiomyopathy (ACM) in this Review, providing insights into the molecular mechanisms of this disease.
Editor’s choice - Small-molecule therapeutic boosts spatial memory and motor function in Rett syndrome mice
Rett syndrome is caused by a mutation triggering decreased levels of protein BDNF. Small-molecule BDNF mimetic, LM22A-4, has previously been shown to improve respiratory problems associated with the disease. Now, new research from Lucas Pozzo-Miller and colleagues reveals that LM22A-4 may also improve spatial memory and motor skill defects in a Rett syndrome mouse model. Read the Research article here, and the press release here.
Featured article - Imaging of viral neuroinvasion in the zebrafish reveals that Sindbis and chikungunya viruses favour different entry routes
In this Research article from Gabriella Passoni and co-workers, imaging of neuroinvasion in zebrafish shows that chikungunya virus first infects the blood-brain barrier, whereas Sindbis virus relies on axonal transport.
Why should you publish your next paper in Disease Models & Mechanisms?
From single-celled organisms to patient-derived models, cancer to neurodegeneration, Disease Models & Mechanisms publishes the best original research and resources that focus on the use of model systems to better understand, diagnose and treat human disease. Submit your paper here.
Transfer to Biology Open
If your submission to Disease Models & Mechanisms is unsuccessful, did you know you can transfer your paper and any reviews directly to our sister journal, Biology Open? The majority of papers transferred with reviews are accepted for publication. Find out how here.